1292 related articles for article (PubMed ID: 14990635)
1. Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial.
Sundstrøm S; Bremnes R; Aasebø U; Aamdal S; Hatlevoll R; Brunsvig P; Johannessen DC; Klepp O; Fayers PM; Kaasa S
J Clin Oncol; 2004 Mar; 22(5):801-10. PubMed ID: 14990635
[TBL] [Abstract][Full Text] [Related]
2. Cost-utility analysis of short- versus long-course palliative radiotherapy in patients with non-small-cell lung cancer.
van den Hout WB; Kramer GW; Noordijk EM; Leer JW
J Natl Cancer Inst; 2006 Dec; 98(24):1786-94. PubMed ID: 17179480
[TBL] [Abstract][Full Text] [Related]
3. A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer.
Liao Z; Komaki R; Milas L; Yuan C; Kies M; Chang JY; Jeter M; Guerrero T; Blumenschien G; Smith CM; Fossella F; Brown B; Cox JD
Clin Cancer Res; 2005 May; 11(9):3342-8. PubMed ID: 15867233
[TBL] [Abstract][Full Text] [Related]
4. Comparison of curative and palliative radiotherapy efficacy in unresectable advanced non-small cell lung cancer patients with or without metastasis.
Unlu I; Diniz G; Komurcuoglu B; Gayaf M; Gokce T; Karadogan I; Akcay C
Saudi Med J; 2006 Jun; 27(6):849-53. PubMed ID: 16758049
[TBL] [Abstract][Full Text] [Related]
5. Escalated hyperfractionated accelerated radiation therapy for locally advanced non-small cell lung cancer: a clinical phase II trial.
Chen GY; Jiang GL; Qian H; Wang LJ; Yang HJ; Fu XL; Wu KL; Zang Z; Zhao S
Radiother Oncol; 2004 May; 71(2):157-62. PubMed ID: 15110448
[TBL] [Abstract][Full Text] [Related]
6. Escalated dose for non-small-cell lung cancer with accelerated hypofractionated three-dimensional conformal radiation therapy.
Thirion P; Holmberg O; Collins CD; O'Shea C; Moriarty M; Pomeroy M; O'Sullivan C; Buckney S; Armstrong J
Radiother Oncol; 2004 May; 71(2):163-6. PubMed ID: 15110449
[TBL] [Abstract][Full Text] [Related]
7. Steep dose-response relationship for stage I non-small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy.
Onimaru R; Fujino M; Yamazaki K; Onodera Y; Taguchi H; Katoh N; Hommura F; Oizumi S; Nishimura M; Shirato H
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):374-81. PubMed ID: 18029106
[TBL] [Abstract][Full Text] [Related]
8. Palliative treatment of advanced non small cell lung cancer with weekly fraction radiotherapy.
Bhatt ML; Mohani BK; Kumar L; Chawla S; Sharma DN; Rath GK
Indian J Cancer; 2000 Dec; 37(4):148-52. PubMed ID: 12018566
[TBL] [Abstract][Full Text] [Related]
9. Palliative thoracic radiotherapy in locally advanced non-small cell lung cancer: can quality-of-life assessments help in selection of patients for short- or long-course radiotherapy?
Sundstrøm S; Bremnes RM; Brunsvig P; Aasebø U; Kaasa S;
J Thorac Oncol; 2006 Oct; 1(8):816-24. PubMed ID: 17409965
[TBL] [Abstract][Full Text] [Related]
10. Accelerated radical radiotherapy for non-small cell lung cancer using two common regimens: a single-centre retrospective study of outcome.
Pemberton LS; Din OS; Fisher PM; Hatton MQ
Clin Oncol (R Coll Radiol); 2009 Apr; 21(3):161-7. PubMed ID: 19111452
[TBL] [Abstract][Full Text] [Related]
11. Results of the Dutch National study of the palliative effect of irradiation using two different treatment schemes for non-small-cell lung cancer.
Kramer GW; Wanders SL; Noordijk EM; Vonk EJ; van Houwelingen HC; van den Hout WB; Geskus RB; Scholten M; Leer JW
J Clin Oncol; 2005 May; 23(13):2962-70. PubMed ID: 15860852
[TBL] [Abstract][Full Text] [Related]
12. Hypofractionated high-dose proton beam therapy for stage I non-small-cell lung cancer: preliminary results of a phase I/II clinical study.
Hata M; Tokuuye K; Kagei K; Sugahara S; Nakayama H; Fukumitsu N; Hashimoto T; Mizumoto M; Ohara K; Akine Y
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):786-93. PubMed ID: 17379439
[TBL] [Abstract][Full Text] [Related]
13. Toxicity and outcome results of a class solution with moderately hypofractionated radiotherapy in inoperable Stage III non-small cell lung cancer using helical tomotherapy.
Bral S; Duchateau M; Versmessen H; Engels B; Tournel K; Vinh-Hung V; De Ridder M; Schallier D; Storme G
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1352-9. PubMed ID: 20056350
[TBL] [Abstract][Full Text] [Related]
14. The role of palliative radiotherapy in locally advanced non-small cell lung cancer.
Cetingoz R; Kentli S; Uruk O; Demirtas E; Sen M; Kinay M
Neoplasma; 2001; 48(6):506-10. PubMed ID: 11949846
[TBL] [Abstract][Full Text] [Related]
15. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
16. Inoperable non-small cell lung cancer: palliative radiotherapy with two weekly fractions.
Vyas RK; Suryanarayana U; Dixit S; Singhal S; Bhavsar DC; Neema JP; Baboo HA
Indian J Chest Dis Allied Sci; 1998; 40(3):171-4. PubMed ID: 9919836
[TBL] [Abstract][Full Text] [Related]
17. Small-volume image-guided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fields for patients with inoperable Stage I nonsmall cell lung carcinomas.
Fukumoto S; Shirato H; Shimzu S; Ogura S; Onimaru R; Kitamura K; Yamazaki K; Miyasaka K; Nishimura M; Dosaka-Akita H
Cancer; 2002 Oct; 95(7):1546-53. PubMed ID: 12237924
[TBL] [Abstract][Full Text] [Related]
18. Prospective study of palliative hypofractionated radiotherapy (8.5 Gy x 2) for patients with symptomatic non-small-cell lung cancer.
Cross CK; Berman S; Buswell L; Johnson B; Baldini EH
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1098-105. PubMed ID: 15001250
[TBL] [Abstract][Full Text] [Related]
19. Standard thoracic radiotherapy with or without concurrent daily low-dose carboplatin in elderly patients with locally advanced non-small cell lung cancer: a phase III trial of the Japan Clinical Oncology Group (JCOG9812).
Atagi S; Kawahara M; Tamura T; Noda K; Watanabe K; Yokoyama A; Sugiura T; Senba H; Ishikura S; Ikeda H; Ishizuka N; Saijo N;
Jpn J Clin Oncol; 2005 Apr; 35(4):195-201. PubMed ID: 15845568
[TBL] [Abstract][Full Text] [Related]
20. CT-planned accelerated hypofractionated radiotherapy in the radical treatment of non-small cell lung cancer.
Lester JF; Macbeth FR; Brewster AE; Court JB; Iqbal N
Lung Cancer; 2004 Aug; 45(2):237-42. PubMed ID: 15246196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
